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Abstract Methicillin-resistant Staphylococcus aureus
(MRSA) is one of the major nosocomial pathogens
responsible for a wide spectrum of infections and the
emergence of bacterial resistance to antibiotics has lead to
treatment drawbacks towards large number of drugs. For-
mation of biofilms is the main contributing factor to anti-
biotic resistance. The development of reliable processes for
the synthesis of zinc oxide nanoparticles is an important
aspect of nanotechnology today. Zinc oxide and titanium
dioxide nanoparticles comprise well-known inhibitory and
bactericidal effects. Emergence of antimicrobial resistance
by pathogenic bacteria is a major health problem in recent
years. This study was designed to determine the efficacy of
zinc and titanium dioxide nanoparticles against biofilm
producing methicillin-resistant S. aureus. Biofilm produc-
tion was detected by tissue culture plate method. Out of 30
MRSA isolates, 22 isolates showed strong biofilm pro-
duction and 2 showed weak and moderate biofilm forma-
tion. Two strong and weak biofilm-producing methicillin-
resistant S. aureus isolates were subjected to antimicrobial
activity using commercially available zinc and titanium
dioxide nanoparticles. Thus, the nanoparticles showed
considerably good activity against the isolates, and it can
be concluded that they may act as promising, antibacterial
agents in the coming years.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is one
of the major nosocomial pathogens responsible for a wide
spectrum of infections which includes skin and soft tissue
infections, pneumonia, bacteraemia, surgical site infections
(SSI), and catheter-related infections (De San et al. 2007;
Emily and Trish 2011). The emergence of bacterial resistance
to antibiotics and its distribution are major health problems
that lead to treatment failure for a large number of drugs
(Julian and Dorothy 2010). Biofilm formation is the main
contributing factor to bacterial antibiotic resistance. Staphy-
lococcus aureus becomes resistant by producing an extra-
cellular polymeric substance (EPS) matrix that is composed
of polysaccharides, nucleic acids, proteins and lipids (Davey
and O’Toole 2000; Kokare et al. 2009). Sessile bacteria
embedded in this EPS matrix are able to withstand the host
immune responses and thereby become less susceptible to
antibiotics, which in turn fail to penetrate inside the biofilm.
Therefore, there is an urgent clinical need to develop novel
antibacterial therapies to destroy biofilms which will hence-
forth, reduce healthcare infections. Nanostructured materials
are attracting a great deal of consideration because of their
capability and selectivity, particularly in biological and
pharmaceutical applications (Wu et al. 2003; Fortner et al.
2005; Li et al. 2005). The most studied aspects of nano-
technology field are its ability to tussle bacterial infections
through the production of nanoparticles (Luo et al. 2007). The
antimicrobial activities of metal oxide nanoparticles and their
selective toxicity to biological systems suggest their potential
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applications as therapeutics, diagnostics, surgical devices and
nanomedicine-based antibacterial agents (Sawai 2003; Laura
et al. 2006; Reddy et al. 2007; Sobha et al. 2010). The
compensation of using these metal oxides’ nanoparticles as
antimicrobial agents is their better efficiency on resistant
bacteria, less toxicity and heat resistance, and among metal
oxide nanoparticles, ZnO nanoparticles have many signifi-
cant features such as chemical and physical stability, high
catalysis activity and effective antibacterial activity (Kalyani
et al. 2006; Matei et al. 2008). Titanium dioxide nanoparticles
(TiO2) decompose organic compounds by the formation and
constant release of hydroxyl radicals and superoxide ions
when exposed to non-lethal ultraviolet (UV) light, which is
highly efficient in inhibiting the growth of MRSA (Shah et al.
2008). This potent oxidizing power of TiO2 NPs typically
results in case of bacteria and other organic substances (Cho
et al. 2005; Fujishima et al. 2000; Shiraishi and Hirai 2008).
The small nanometer-scale TiO2 and ZnO nanoparticles
impose several effects that govern its antibacterial action.
Thus, the present study was designed to evaluate the anti-
bacterial activity of ZnO and TiO2 NPs against biofilm-pro-
ducing MRSA isolates.
Materials and methods
The present study was conducted in the Department of
Biotechnology, Karunya University, Coimbatore, India,
from December 2010 to May 2011.
ZnO and TiO2 NPs
Commercially synthesized ZnO and TiO2 NPs were pur-
chased from Sigma-Aldrich, St. Louis, MO. The reported
‘‘as manufactured’’ sizes were: ZnO NPs \100 nm and
TiO2 NPs\50 nm. The subsequent dilutions were made in
autoclaved double-distilled water.
Preparation of ZnO NPs and TiO2 NPs suspension
(Ansari et al. 2009)
One hundred milligrams of ZnO NPs and TiO2 NPs was
added to 10 ml of sterile MQ water and shaken vigorously.
The suspending solution was treated by ultrasound (100 w,
40 kHz) for 30 min, autoclaved at 121 C for 20 min and
then cooled down to room temperature. The reason for the
use of sonication was to break down the agglomerates and
aggregation of nanoparticles and make their dispersions.
Bacterial isolates, medium and cultivation
The bacterial isolates from the clinical specimens were
isolated and characterized as MRSA and were used as test
organisms to evaluate the antimicrobial effects of ZnO and
TiO2 NPs. All the isolates were cultured aerobically at
37 C on Mueller–Hinton Agar (MHA) plates, Hi-Media
(Mumbai, India).
Antibiotic susceptibility testing
The antibiotic susceptibility pattern was determined by
modified Kirby Bauer disc diffusion method against the
following antibiotics (drug concentration in lg): amoxyclav
(30), ampicillin (10), ampicillin/sulfbactam (10/10), cefoxitin
(30), co-trimoxazole (25), clindamycin (2), chloramphenicol
(30), ciprofloxacin (30), fusidic acid (30), gentamicin (10),
levofloxacin (10), linezolid (30), minocycline (30), mupiro-
cin (5), ofloxacin (5), rifampicin (5), teicoplanin (30), tetra-
cycline (30) and vancomycin (30). The Mueller–Hinton agar
(MHA) plate supplemented with 2 % NaCl was swabbed
with MRSA culture with turbidity matching 0.5 McFarland
standard, by a sterile cotton swab and the antibiotics
discs were laid on the surface (CLSI 2012).
Detection of biofilm production
Overnight grown bacterial culture in trypticase soya broth
(TSB) supplemented with 1 % glucose was diluted 1:100
and 200 ll of the bacterial culture was inoculated in
96-well flat bottom polystyrene microtitre plates (Tarsons,
India) (Christensen et al. 1985). Incubation was carried out
at 35 C for 24 h. Cultures were then aspirated and the
wells were washed three times with phosphate-buffered
saline, pH 7.2. The plates were then air dried overnight and
stained with 0.1 % crystal violet. The optical density of the
wells was measured at 570 nm using micro-ELISA auto
reader. An optical density of \0.120 for nonbiofilm pro-
ducer, 0.120–0.240 for moderate biofilm producer, and
[0.240 was chosen to distinguish strong biofilm producers.
Sterile TSB was used as a negative control (blank). To
compensate for background absorbance, the OD reading
value of blank was deducted from the test values. Intensity
of biofilm was classified as given by Mathur et al. (2006).
Determination of antimicrobial activity
by well-diffusion method
The ZnO and TiO2 NPs were tested for antimicrobial
activity by well-diffusion method against strong and weak
biofilm-producing MRSA. The pure cultures of MRSA
were subcultured onto sterile Luria–Bertani broth and
incubated at 37 C for 16–18 h. After 16–18 h, the optical
density of the above inoculated culture was checked to be
around 0.1 at 600 nm to obtain 1 9 108 CFU/ml. Wells of
6-mm diameter were made on Mueller–Hinton agar plates
using gel puncture. Each strain was swabbed uniformly
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onto the individual plates using sterile cotton swabs. Using
a micropipette, 100, 200 and 500 lg/ml of ZnO and TiO2
nanoparticles solution was poured onto each of three wells
on all plates. After incubation at 35 C for 18 h, the dif-
ferent levels of zone of inhibition were measured.
Results
Antibiotic susceptibility testing
All the isolates subjected to the study exhibited varying
resistance patterns against 19 commonly used antibiotics.
Vancomycin was found to be the most effective drug overall
against MRSA as none of the tested isolates exhibited
resistance against it. However, cefoxitin, ampicillin, genta-
micin and co-trimoxazole developed 100 % resistance ren-
dering them incapable to act as effective drugs. The
percentage of resistance to antibiotics such as chloram-
phenicol, ciprofloxacin, ofloxacin, amoxyclav, linezolid,
tetracycline, teicoplanin, clindamycin, rifampicin, fusidic
acid, mupirocin, amoxycillin/sulfbactam, levofloxacin and
minocycline was found to be in the order of 95, 90, 83, 80, 76,
70, 67, 60, 57, 57, 50, 44, 43 and 36 %, respectively (Fig. 1).
Detection of biofilm production
All the MRSA isolates were subjected to the standard TCP
assay and 22 tested isolates displayed biofilm positive
phenotype in TSB medium, after incubation for 18 and
24 h, respectively. Optical density (OD) of stained adher-
ent bacteria was determined with a micro-ELISA auto
reader (model 680, Bio-Rad) at wavelength of 570 nm
(Table 1).
Antibiotic-resistant patterns of biofilm
and nonbiofilm-producing MRSA
Antibiotic-resistant patterns of biofilm and nonbiofilm-
producing MRSA isolates are illustrated in Fig. 2. All the
biofilm-producing isolates showed 100 % resistance to
cefoxitin followed by tetracycline, chloramphenicol, cip-
rofloxacin, co-trimoxazole, amoxyclav, gentamicin and
ampicillin. Both biofilm producer and nonbiofilm producer
exhibited 100 % resistance to cefoxitin followed by gen-
tamicin, ampicillin and co-trimoxazole. However, resis-
tance to other antibiotics such as linezolid (54 vs. 47 %),
teicoplanin (73 vs. 47 %), minocycline (64 vs. 57 %),
mupirocin (73 vs. 63 %), ofloxacin (64 vs. 57 %), clinda-
mycin (64 vs. 42 %), fusidic acid (81 vs. 42 %), amoxy-
cillin/sulfbactam (45 vs. 36 %), levofloxacin (81 vs. 57 %),
and rifampicin (45 vs. 42 %) was comparatively higher
among biofilm producers than among nonbiofilm produc-
ers. Resistance among biofilm producers to ciprofloxacin
was also higher (100 vs. 47 %) when compared with
nonbiofilm producers.
Antimicrobial activity of ZnO and TiO2 NPs against
MRSA
The antimicrobial activity of ZnO and TiO2 NPs was
investigated against biofilm-producing MRSA using well-
diffusion method. The mean of four replicates of the
diameter of inhibition zones (in millimeters) around each
well with ZnO and TiO2 NPs solution is represented in
Table 2. It was found that at all concentrations, ZnO NPs
were able to inhibit bacterial growth and a maximum zone
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minimum zone of inhibition of 12 and 14 mm at 100 lg/ml
were observed against strong and weak biofilm-producing
MRSA isolates, respectively. Similarly, TiO2 NPs were
able to inhibit bacterial growth and a maximum zone of
inhibition of 14 mm at 500 lg/ml and a minimum zone of
inhibition of 11 and 12 mm at 100 lg/ml were observed
against strong and weak biofilm-producing MRSA isolates,
respectively.
Discussion
MRSA has the ability to form biofilms, which contribute to
antibiotic resistance and other related infections (Paintsil
2007; Kwon et al. 2008). In this study, 73.3 % of MRSA
isolates were found to produce biofilms. This is compara-
tively higher than 14.7, 52.7 and 56.6 % as reported by
Mathur et al. (2006); Gundogan et al. (2011) and Zmantar
et al. (2009). The present study employed the TCP method
for the detection of biofilm in MRSA. It is the easiest and
cheapest technique available for routine laboratory use
(Ruzicka et al. 2010). We compared the differences in
antibiotic-resistant patterns between the biofilm and non-
biofilm-producing MRSA isolates. Cha et al. (2011) sug-
gested that biofilms are more resistant to killing than
planktonic cells are which supports the findings of the
present study. Cha et al. (2011) demonstrated that dapto-
mycin and tigecycline activities in biofilms were better
than those of the other conventional antibiotics (vanco-
mycin, clindamycin, gentamicin, and linezolid). But, in the
present study, vancomycin, ampicillin/sulfbactam, rifam-
picin and linezolid antibiotics showed better activities
against biofilms. Shrestha et al. (2009) found that MRSA
isolates were susceptible to vancomycin, teicoplanin and
linezolid, whereas in this study, we observed complete
susceptibility against vancomycin only and resistance to
teicoplanin and linezolid.
Zinc oxide has a very good potential to move into the
clinical field (Shopsin et al. 1999). The antibacterial
activity of ZnO NPs against many isolates has been well
documented like in Staphylococcus spp. (Huang et al.
2008), K. pneumoniae (Lee, 2009), and Pseudomonas spp.
(Jiang et al. 2009), Escherichia coli (Zhang et al. 2009).
Rizwan et al. (2010) have stated that when the concen-
tration of ZnO nanoparticles is increased it resulted in the
augmenting of zone size. Whereas in this study, there was
no significant difference in the zone of inhibition at 100
and 200 lg/ml, but there was an increase in size at
500 lg/ml. Ansari et al. (2009) reported that employing
increased concentration of ZnO NPs, did not show any
steady increase in the zone size. Previous researchers have
proposed that release of H2O2 might be one of the pos-
sible mechanisms for antibacterial activity of ZnO-NPs
(Yamamoto 2001; Yamamoto et al. 2004). The toxicity of
ZnO and of other metal oxides towards human beings is
observed at higher concentrations, but low concentrations
of ZnO are non-toxic towards human cells. The occur-
rence of insoluble zinc in the well-diffusion agar method
clearly indicates the antibacterial activity of ZnO NPs. On
the other hand, ZnO NPs are much more effective in
Fig. 2 Antibiotic-resistant
patterns of biofilm and
nonbiofilm-producing,
methicillin-resistant S. aureus
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Zone of diameter in mm (mean of four replicates)
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controlling the growth of various microorganisms (Sawai
2003).
Gelover et al. (2006) reported that TiO2 NPs are the
mostly studied for their photocatalytic antimicrobial
activity among various NPs. Roy et al. (2010) in their
study suggested that TiO2 NPs failed to exhibit antibac-
terial activity, but upon combination with antibiotics they
were able to inhibit the growth of microorganisms. But
here, TiO2 NPs without any kind of combination inhibited
the growth of MRSA isolates with a maximum zone of
14 mm at 500 lg/ml and a minimum zone of 11 and
12 mm at 100 lg/ml against strong and weak MRSA
isolates. Zhang et al. (2009) have suggested the possible
mechanisms involving the interaction of nanomaterials
with the biological molecules. The author documented
that microorganisms carry a negative charge while metal
oxides carry a positive charge which creates an ‘‘elec-
tromagnetic’’ attraction between the microbe and treated
surface concluding that once the contact is made, the
microbe is oxidized and dead instantly (Zhang and Chen
2009).
Thus, the antimicrobial activity of the nanoparticles
showed that the ZnO and TiO2 NPs have great potential to
be used as antimicrobial agents against microorganisms.
Resistance to antimicrobial agents by pathogenic bacteria
has emerged in recent years and it is a major health
problem. This study would serve as a useful guidance for
the physicians and also other healthcare-associated workers
for the choice of antibiotics and nanoparticles in the
treatment of MRSA biofilm infections. But ZnO NPs and
TiO2 NPs inhibited the growth with a maximum zone of
inhibition of 16 mm (strong), 17 mm (weak) and 14 mm
(for both strong and weak) at 500 lg/ml, respectively,
against biofilm producing MRSA isolates. The study con-
firmed that strong MRSA biofilm had increased resistance
to most of the antibiotics. Therefore, there is a need for a
better understanding of the properties of MRSA biofilm-
mediated diseases. For instance, the development of
metallic nanoparticles covering the surfaces of ambulatory
and other medical devices would provide an alternative
means to decrease the microorganism colonization and
device-associated infection, including ventilator-associated
pneumonia, central venous catheter infections and catheter-
associated urinary tract infections.
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